Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Biotech M&A Continues to Climb the Curve

The trajectory of biotech M&A has been steep in 2015, so the $7.2bn acquisition of Receptos by oncology powerhouse Celgene, increases the gradient even further. This deal came out of left field, especially as commentators were still raking over the sizable partnering deal Celgene has just cemented with Juno Therapeutics in immuno-oncology.

Read the full article…

Posted in M&A Finance and Funding, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Merck announces collaboration with Advaxis

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

Mr Pascal Soriot – AstraZeneca – Executive Leadership Series

Authored by James Sheppard

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , | Leave a comment

ADC Therapeutics executives on fast track with funding and partners

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

AstraZeneca makes play in ADC market

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

AstraZeneca Binds to biologics for new strategy Horizon

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

David Motts’ NEA weighs in on rare diseases

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Prosensa & GSK pool resources to drive Drisapersen in Duchenne

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Soriot to apply therapy to AstraZeneca

On 26th of April 2012 David Brennan stepped down as AstraZeneca’s CEO after 6 years in the job. David Brennan had risen through the ranks at AstraZeneca first at Astra and later after the merger with ICI spin-off Zeneca. Brennan had been criticised by investors for failing to sure up the companies pipeline as a wave of patents expired. Yet, when Brennan announced he was leaving, AstraZeneca’s share price fell dramatically and took nearly two months to recover.

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , | 2 Comments




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap